Coverage for weight loss is a different story: only 13 states cover obesity-indicated GLP-1s as of January 2026, and that number has been shrinking as states face budget pressure
Expect fast weeks, slow weeks, and the occasional flat week even while everything is working
Additional classifications include: Among the pediatric population, two GLP-1 agonists are FDA-approved as an adjust to lifestyle changes for weight management among adolescents ages 12 and older: liraglutide and semaglutide
Want to enhance their weight loss efforts
With regard to non-drug treatment, the most suitable is psychotherapy, whose main effects are to change the environment, improving the individuals behavior, such as helping with decision-making and strategies for dealing with day-to-day problems
Providers assess individual risks, screen for contraindications such as recent pancreatitis, and tailor dosing to improve tolerability